Blog
Study argues for broader genetic testing of cancer patients
January 14, 2021
Cancer patients would benefit from blanket genetic testing, but half of inherited cancer-related gene mutations may go undetected under current “strict clinical practice [testing] guidelines,” as noted in Mayo Clinic’s new research published in JAMA Oncology. Detecting inherited cancer-related gene mutations would result in modified treatment in many of the cases and could help families better address hereditary risk, researchers say.
A new blood-based test could make TBI diagnosis quicker and cheaper
January 7, 2021
At last count, in 2014, there were nearly 3 million TBI-related emergency room visits, hospitalizations and deaths in the U.S., according to the CDC. TBI diagnosis often involves a neurological exam covering thinking, motor function, sensory function, coordination and reflexes. A CT scan, usually in the emergency room, can uncover fractures, hemorrhage, blood clots, brain bruising and swelling.
With iSpecimen support, researchers drive growing market for regenerative medicine
December 18, 2020
Harvard scientists reported earlier this month that they essentially cured blindness in lab mice by delivering youth-restoring genes into the animals’ retinas, thus “turning back the clock” on their cells. The achievement perfectly parallels the breakthroughs medical researchers are pursuing for humans in the field of regenerative medicine – the repair, rejuvenation and replacement of diseased or damaged tissues and organs.
COVID-19 immunity shows signs of endurance
December 1, 2020
Some good news to be grateful for: New evidence suggests that COVID-19 immunity could last a long time after infection or vaccination – months, years, maybe even decades. That’s a good sign for the vaccination programs expected to commence in coming months.
Lung fluid samples contribute to story of COVID-19
November 12, 2020
Supercomputing analysis of cellular gene expression data from COVID-19 patients’ lung fluid samples suggests potential new paths of investigation into treating the disease.
Researchers discover new biomarkers for stroke
October 29, 2020
Many strokes are missed when a clinician first examines the patient. That’s often because the classic stroke symptoms – drooping face, numbness in the arm, slurred speech – aren’t as obvious as they are in the most severely presenting cases. Despite less-obvious symptoms, these events can still lead to disability and death. Confirming a stroke […]
Urgent simultaneous requests for COVID-19 and ovarian cancer specimens
October 21, 2020
If you’re a client or regular reader, you know we’re committed to advancing the precision medicine revolution – the use of massive amounts of patient data to extract new insights about individuals, treatments and prognosis.
Older research could bring new insights for COVID-19 long haulers
October 6, 2020
Understanding the mechanisms behind the development of mono and CFS may well shed light on comparable mechanisms related to developing COVID-19 and “long COVID,” a condition characterized by CFS-like symptoms (problems with energy, memory and concentration) that endure for weeks and months after the acute COVID-19 infection phase.
Big volumes of specimen data help improve ovarian cancer prognosis
September 24, 2020
Human biospecimens contain massive volumes of potential data that can help researchers glean surprising new insights. That’s the case for an international team of researchers who have discovered that genetic signatures in ovarian cancer tissue can predict the patient’s survival more accurately than the combination of patient age and cancer stage.
The public health pro’s best friend
September 14, 2020
Labs and other canine friends can distinguish urine from a patient who has tested positive from cans of urine from noninfected patients, according to the Washington Post. Faced with an array of controls in the lab, they will even walk right by cake batter.
Previous |
- © 2021 iSpecimen, Inc.
- All rights reserved.
|
|